Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
0.6580
-0.0544 (-7.64%)
At close: May 1, 2026, 4:00 PM EDT
0.6890
+0.0310 (4.71%)
Pre-market: May 4, 2026, 4:22 AM EDT
Clearmind Medicine Market Cap
Clearmind Medicine has a market cap or net worth of $1.37 million as of May 1, 2026. Its market cap has decreased by -72.40% in one year.
Market Cap
1.37M
Enterprise Value
-8.96M
1-Year Change
-72.40%
Ranking
Category
Stock Price
$0.66
Market Cap Chart
Since August 16, 2021, Clearmind Medicine's market cap has decreased from $26.16M to $1.37M, a decrease of -94.75%. That is a compound annual growth rate of -46.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 1.37M | -49.37% |
| Dec 31, 2025 | 2.71M | -55.12% |
| Dec 31, 2024 | 6.05M | 27.14% |
| Dec 29, 2023 | 4.76M | -39.12% |
| Dec 30, 2022 | 7.82M | -59.15% |
| Dec 27, 2021 | 19.13M | -26.88% |
| Aug 16, 2021 | 26.16M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Valion Bio | 2.65M |
| Virax Biolabs Group | 2.63M |
| Scinai Immunotherapeutics | 2.46M |
| Calidi Biotherapeutics | 2.39M |
| Bone Biologics | 2.36M |
| Adial Pharmaceuticals | 2.21M |
| Propanc Biopharma | 2.16M |
| Silexion Therapeutics | 1.99M |